BG106074A - N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists - Google Patents

N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists

Info

Publication number: BG106074A
Authority: BG; Bulgaria
Prior art keywords: neurokinin; alkyl; hydrogen; optionally substituted; phenyl
Prior art date: 1999-04-06

Application number

BG106074A

Other languages

Bulgarian (bg)

English (en)

Inventor

Peter Bernstein

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-06

Filing date

2001-11-01

Publication date

2002-05-31

2001-11-01 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2002-05-31 Publication of BG106074A publication Critical patent/BG106074A/xx

Links

VFTQJCVZNTYOKM-UHFFFAOYSA-N n-(4-amino-2-phenylbutyl)naphthalene-1-carboxamide Chemical class C=1C=CC2=CC=CC=C2C=1C(=O)NCC(CCN)C1=CC=CC=C1 VFTQJCVZNTYOKM-UHFFFAOYSA-N 0.000 title 1
239000002742 neurokinin 1 receptor antagonist Substances 0.000 title 1
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
229910052739 hydrogen Inorganic materials 0.000 abstract 3
239000001257 hydrogen Substances 0.000 abstract 3
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
101000831616 Homo sapiens Protachykinin-1 Proteins 0.000 abstract 2
102100024304 Protachykinin-1 Human genes 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
ADNPLDHMAVUMIW-CUZNLEPHSA-N substance P Chemical compound C([C@@H](C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@@H](N)CCCN=C(N)N)C1=CC=CC=C1 ADNPLDHMAVUMIW-CUZNLEPHSA-N 0.000 abstract 2
125000000882 C2-C6 alkenyl group Chemical group 0.000 abstract 1
102000003141 Tachykinin Human genes 0.000 abstract 1
125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
125000003118 aryl group Chemical group 0.000 abstract 1
125000001475 halogen functional group Chemical group 0.000 abstract 1
125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 abstract 1
230000000144 pharmacologic effect Effects 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
108060008037 tachykinin Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/57—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Immunology (AREA)
Hospice & Palliative Care (AREA)
Rheumatology (AREA)
Otolaryngology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

BG106074A 1999-04-06 2001-11-01 N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists BG106074A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9907571.5A GB9907571D0 (en)	1999-04-06	1999-04-06	Compounds
PCT/GB2000/001252 WO2000059873A1 (en)	1999-04-06	2000-04-03	N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists

Publications (1)

Publication Number	Publication Date
BG106074A true BG106074A (en)	2002-05-31

Family

ID=10850835

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG106074A BG106074A (en)	1999-04-06	2001-11-01	N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists

Country Status (25)

Country	Link
US (3)	US6476077B1 (de)
EP (1)	EP1169302B1 (de)
JP (1)	JP2002541137A (de)
KR (1)	KR20010102580A (de)
CN (2)	CN1345307A (de)
AT (1)	ATE277893T1 (de)
AU (1)	AU3569200A (de)
BG (1)	BG106074A (de)
BR (1)	BR0009582A (de)
CA (1)	CA2368240A1 (de)
CZ (1)	CZ20013574A3 (de)
DE (1)	DE60014343T2 (de)
EE (1)	EE200100520A (de)
GB (1)	GB9907571D0 (de)
HK (1)	HK1044145A1 (de)
HU (1)	HUP0200707A3 (de)
IL (1)	IL145645A0 (de)
IS (1)	IS6087A (de)
NO (1)	NO20014855L (de)
PL (1)	PL350568A1 (de)
SK (1)	SK13012001A3 (de)
TR (1)	TR200102875T2 (de)
UA (1)	UA67839C2 (de)
WO (1)	WO2000059873A1 (de)
ZA (1)	ZA200108176B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9907571D0 (en) *	1999-04-06	1999-05-26	Zeneca Ltd	Compounds
GB0019008D0 (en) *	2000-08-04	2000-09-27	Astrazeneca Ab	Therapeutic compounds
SE0201938D0 (sv) *	2002-06-20	2002-06-20	Astrazeneca Ab	New process
JP2006505461A (ja) *	2002-11-05	2006-02-16	アストラゼネカ・アクチエボラーグ	錠止蓋を有する安全容器および蓋を錠止する方法
JP2006512363A (ja) *	2002-12-20	2006-04-13	アストラゼネカ・アクチエボラーグ	ピペリジンアミン化合物およびその使用
JP2008514612A (ja) *	2004-09-23	2008-05-08	ミシャロウ、アレクサンダー	対抗適応を誘発することにより神経伝達物質系を調節する方法
US20080045610A1 (en) *	2004-09-23	2008-02-21	Alexander Michalow	Methods for regulating neurotransmitter systems by inducing counteradaptations
WO2013004766A1 (en)	2011-07-04	2013-01-10	Ferrari Giulio	Nk-1 receptor antagonists for treating corneal neovascularisation
SMT201900719T1 (it)	2015-05-18	2020-01-14	Nerre Therapeutics Ltd	Antagonista del recettore nk-1/nk-3 per il trattamento delle vampate di calore
US20210015834A1 (en)	2018-02-26	2021-01-21	Ospedale San Raffaele S.R.L.	Nk-1 antagonists for use in the treatment of ocular pain
AU2019233606B2 (en)	2018-03-14	2024-10-03	KaNDy Therapeutics Limited	Novel pharmaceutical formulation comprising dual NK-1/NK-3 receptor antagonists
RU2697414C1 (ru)	2018-05-11	2019-08-14	Общество с ограниченной ответственностью "АЙ БИ ДИ Терапевтикс"	Новый антагонист тахикининовых рецепторов и его применение
WO2021180885A1 (en)	2020-03-11	2021-09-16	Ospedale San Raffaele S.R.L.	Treatment of stem cell deficiency
US12533358B1 (en)	2025-05-14	2026-01-27	Bayer Consumer Care Ag	Methods of treatment with elinzanetant

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI97540C (fi)	1989-11-06	1997-01-10	Sanofi Sa	Menetelmä terapeuttisesti käyttökelpoisten, aromaattisesti substituoitujen piperidiini- ja piperatsiinijohdannaisten valmistamiseksi
JPH08511522A (ja) *	1993-06-07	1996-12-03	メルクエンドカンパニーインコーポレーテッド	ニューロキニンアンタゴニストとしてのスピロ置換アザ環
US5824678A (en) *	1994-08-15	1998-10-20	Merck Sharp & Dohme Ltd.	Morpholine derivatives and their use as therapeutic agents
AU5522498A (en)	1996-12-13	1998-07-03	Merck & Co., Inc.	Substituted aryl piperazines as modulators of chemokine receptor activity
GB9907571D0 (en) *	1999-04-06	1999-05-26	Zeneca Ltd	Compounds
IL157456A0 (en) *	2001-03-21	2004-03-28	Pharmacopeia Inc Pharmacopeia	Aryl and biaryl compounds having mch modulatory activity

1999
- 1999-04-06 GB GBGB9907571.5A patent/GB9907571D0/en not_active Ceased
2000
- 2000-03-04 UA UA2001117535A patent/UA67839C2/uk unknown
- 2000-04-03 KR KR1020017012692A patent/KR20010102580A/ko not_active Withdrawn
- 2000-04-03 JP JP2000609386A patent/JP2002541137A/ja active Pending
- 2000-04-03 DE DE60014343T patent/DE60014343T2/de not_active Expired - Fee Related
- 2000-04-03 BR BR0009582-6A patent/BR0009582A/pt not_active IP Right Cessation
- 2000-04-03 AU AU35692/00A patent/AU3569200A/en not_active Abandoned
- 2000-04-03 IL IL14564500A patent/IL145645A0/xx unknown
- 2000-04-03 WO PCT/GB2000/001252 patent/WO2000059873A1/en not_active Ceased
- 2000-04-03 CN CN00805623A patent/CN1345307A/zh active Pending
- 2000-04-03 PL PL00350568A patent/PL350568A1/xx unknown
- 2000-04-03 US US09/937,981 patent/US6476077B1/en not_active Expired - Fee Related
- 2000-04-03 CA CA002368240A patent/CA2368240A1/en not_active Abandoned
- 2000-04-03 EP EP00914298A patent/EP1169302B1/de not_active Expired - Lifetime
- 2000-04-03 AT AT00914298T patent/ATE277893T1/de not_active IP Right Cessation
- 2000-04-03 CZ CZ20013574A patent/CZ20013574A3/cs unknown
- 2000-04-03 EE EEP200100520A patent/EE200100520A/xx unknown
- 2000-04-03 TR TR2001/02875T patent/TR200102875T2/xx unknown
- 2000-04-03 SK SK1301-2001A patent/SK13012001A3/sk unknown
- 2000-04-03 HU HU0200707A patent/HUP0200707A3/hu unknown
- 2000-04-03 HK HK02104758.2A patent/HK1044145A1/zh unknown
- 2000-04-03 CN CNA2004100053467A patent/CN1534017A/zh active Pending
2001
- 2001-09-26 IS IS6087A patent/IS6087A/is unknown
- 2001-10-04 ZA ZA200108176A patent/ZA200108176B/en unknown
- 2001-10-05 NO NO20014855A patent/NO20014855L/no not_active Application Discontinuation
- 2001-11-01 BG BG106074A patent/BG106074A/xx unknown
2002
- 2002-11-01 US US10/286,624 patent/US6586432B2/en not_active Expired - Fee Related
2003
- 2003-06-30 US US10/611,052 patent/US6821973B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US20030092713A1 (en)	2003-05-15
IS6087A (is)	2001-09-26
NO20014855D0 (no)	2001-10-05
DE60014343T2 (de)	2006-03-02
EP1169302A1 (de)	2002-01-09
US20040106610A1 (en)	2004-06-03
US6586432B2 (en)	2003-07-01
IL145645A0 (en)	2002-06-30
AU3569200A (en)	2000-10-23
US6821973B2 (en)	2004-11-23
DE60014343D1 (de)	2004-11-04
EP1169302B1 (de)	2004-09-29
EE200100520A (et)	2002-12-16
CZ20013574A3 (cs)	2002-05-15
BR0009582A (pt)	2001-12-26
TR200102875T2 (tr)	2002-01-21
ZA200108176B (en)	2003-01-06
CN1534017A (zh)	2004-10-06
CA2368240A1 (en)	2000-10-12
KR20010102580A (ko)	2001-11-15
UA67839C2 (uk)	2004-07-15
GB9907571D0 (en)	1999-05-26
NO20014855L (no)	2001-12-06
WO2000059873A1 (en)	2000-10-12
HUP0200707A2 (en)	2002-06-29
ATE277893T1 (de)	2004-10-15
HK1044145A1 (zh)	2002-10-11
HUP0200707A3 (en)	2002-11-28
US6476077B1 (en)	2002-11-05
SK13012001A3 (sk)	2002-04-04
CN1345307A (zh)	2002-04-17
JP2002541137A (ja)	2002-12-03
PL350568A1 (en)	2002-12-16

Publication	Publication Date	Title
BG106074A (en)	2002-05-31	N-(2-phenyl-4-amino-butyl)-1-naphthamides as neurokinin-1 receptor antagonists
CY1105899T1 (el)	2011-02-02	Πυριδινοϋλοπιπepιδινες ως 5-ht1f αγωνιστες
KR20050085991A (en)	2005-08-29	Compounds exhibiting thrombopoietin receptor agonism
EA200200942A1 (ru)	2003-02-27	Фармацевтические композиции, содержащие производные 3-аминоазетидина, новые производные и способ их получения
IL176247A0 (en)	2006-10-05	Cyclopropane compounds and pharmaceutical use thereof
AU2001272476A1 (en)	2001-12-24	Piperidines for use as orexin receptor antagonists
HUT76476A (en)	1997-09-29	Morpholine and thiomorpholine derivatives, process for the preparation thereof and pharmaceutical compositions containing them
TR200400541T4 (tr)	2004-04-21	Terapide faydalı tropan türevleri.
MY130907A (en)	2007-07-31	Piperazine compounds as tachykinins antagonists
PH29923A (en)	1996-09-16	New benzimidazoline-2-oxo-1-carboxylic acid derivatives useful as 5-nt receptor antagonists
TR200001482T2 (tr)	2000-11-21	Fluor içeren 1,4-diikameli piperidin türevleri için aramadde.
CA2284795A1 (en)	1998-10-08	Novel pyrimidine derivatives and processes for the preparation thereof
NO986055D0 (no)	1998-12-22	Nye heterocykliske forbindelser, deres fremstilling, farmas÷ytiske preparat
TW200510440A (en)	2005-03-16	Novel compounds
ATE315022T1 (de)	2006-02-15	Prostaglandinanaloga als ep4-rezeptoragonisten
NZ331060A (en)	2000-01-28	Quinoxalinediones, preparation and pharmaceutical compositions thereof
WO2002051819A3 (en)	2002-12-05	Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
PE20001303A1 (es)	2000-11-30	Derivados de la 4-aroilpiperidina como antagonistas del receptor ccr-3
NO20025640D0 (no)	2002-11-22	Substituerte 1-aminoalkyl-laktamer og deres anvendelse som muscarin-reseptor-antagonister
EA200500087A1 (ru)	2005-06-30	Производные пиперазина
GB9806692D0 (en)	1998-05-27	Benzoheterocyclic distamycin derivatives, process for preparing them and their use as antitumour agents
PE20040682A1 (es)	2004-10-07	Derivados de ciclobutano como antagonistas de nk1
MY134226A (en)	2007-11-30	1,2-dihydropyrazol-3-ones which control inflammatory cyctokines
CO5180536A1 (es)	2002-07-30	Inhibidores de proteasas catepsina
IL136510A0 (en)	2001-06-14	Acylated hetero-alicyclic derivatives and pharmaceutical compositions containing the same